Board of Advisors
The APGxA Board of Advisors
The Board of Advisors for the American Pharmacogenomics Association plays a crucial role in guiding the organization towards its mission of advancing the field of pharmacogenomics. This esteemed panel comprises leading experts from various disciplines, including genetics, pharmacology, bioinformatics, and personalized medicine. Their diverse backgrounds and extensive experience in research, clinical practice, and policy formulation provide invaluable insights and direction for the Association. The Board of Advisors is instrumental in shaping the strategic vision of the Association, ensuring that it remains at the forefront of pharmacogenomic research and its application in clinical settings. Their commitment to fostering collaborations, promoting ethical practices, and advocating for educational initiatives helps the Association to effectively address the complex challenges and opportunities in the rapidly evolving field of pharmacogenomics. Through their guidance, the American Pharmacogenomics Association continues to make significant contributions to personalized medicine, ultimately improving patient care and treatment outcomes.
Be a part of our domestic or international chapters and have a group of like – minded connections and friends waiting. From happy hours, to business round tables and a lot more.
If you are interested in joining us on the Board of Advisors, please go HERE.
United States
Dr. Veronica Abraham, MD, MPH
Uniformed Service University of the Health Sciences (USUHS)
International Division
Dr. Candan Hizel Perry, PhD
Quebeck, Canada
Medpharmgene
Ana De Carmo Campos
Lisboa, Lisbon, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge